Randomized, open-labeled study of prophylactic vs. therapeutic use of Uroxatrol to determine improvements in urinary morbidity following men undergoing prostate brachytherapy

Trial Profile

Randomized, open-labeled study of prophylactic vs. therapeutic use of Uroxatrol to determine improvements in urinary morbidity following men undergoing prostate brachytherapy

Not yet recruiting
Phase of Trial: Phase III

Latest Information Update: 27 Feb 2017

At a glance

  • Drugs Alfuzosin (Primary)
  • Indications Urinary retention
  • Focus Therapeutic Use
  • Most Recent Events

    • 14 Feb 2008 The expected completion date for this trial is now 1 Sep 2005.
    • 25 Sep 2006 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top